CONCENTRIX CORP (CNXC) Stock Analyst Ratings
USA - NASDAQ:CNXC - US20602D1019 - Common Stock
35.84 USD
-0.79 (-2.16%)
ChartMill assigns a Buy % Consensus number of 82% to CNXC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 66.1. This target is 84.42% above the current price.
CNXC was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CNXC.
In the previous month the buy percentage consensus was at a similar level.
CNXC was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-29 | Baird | Maintains | Outperform -> Outperform |
| 2025-09-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-09-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-09-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-18 | Baird | Maintains | Outperform -> Outperform |
| 2025-06-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-06-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-06-27 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-06-26 | Baird | Maintains | Outperform -> Outperform |
| 2025-06-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-06-09 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-03-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-03-27 | B of A Securities | Maintains | Neutral -> Neutral |
| 2025-03-24 | Barrington Research | Maintains | Outperform -> Outperform |
| 2025-01-16 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-03 | Baird | Initiate | Outperform |
| 2024-09-26 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-09-26 | B of A Securities | Maintains | Neutral -> Neutral |
| 2024-09-23 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-09-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-08-28 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2024-06-27 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-06-21 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-29 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-03-27 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-03-27 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2024-03-20 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-01-25 | Barrington Research | Maintains | Outperform -> Outperform |
CONCENTRIX CORP / CNXC FAQ
What is the average price target for CONCENTRIX CORP (CNXC) stock?
11 analysts have analysed CNXC and the average price target is 66.1 USD. This implies a price increase of 84.42% is expected in the next year compared to the current price of 35.84.
What is the consensus rating for CONCENTRIX CORP (CNXC) stock?
The consensus rating for CONCENTRIX CORP (CNXC) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover CONCENTRIX CORP (CNXC) stock?
The number of analysts covering CONCENTRIX CORP (CNXC) is 11.